BRD4 has been shown to be activated in bladder cancer, where it promotes tumor progression, BRD4 knockdown negatively regulated EZH2 transcription through downregulation of C-MYC and exerted anticancer effects37. The gene discussed is MYC; the disease is urinary bladder carcinoma.